| |
| |
|
| Insider
Information: |
Watts Ryan J. |
| Relationship: |
President and CEO, Dir... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
238,067 |
|
|
Indirect Shares
|
2,202,604 |
|
|
| Direct
Value |
$4,756,579 |
|
|
|
Indirect Value
|
$44,008,028 |
|
|
| Total
Shares |
2,440,671 |
|
|
| Total
Value |
$48,764,607 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
14
|
|
Stock
price went up :
|
0
|
4
|
| Stock
price went down : |
0
|
10
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 91.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Denali Therapeutics Inc. |
DNLI |
President and CEO, Dir... |
2024-03-29 |
238,067 |
2024-03-29 |
2,202,604 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2024-03-29 |
4 |
GD |
$0.00 |
$0 |
I/I |
40,000 |
2,202,604 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2024-02-13 |
4 |
S |
$17.29 |
$165,794 |
D/D |
(9,589) |
238,067 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2024-01-09 |
4 |
S |
$19.78 |
$154,640 |
I/I |
(7,818) |
2,268,363 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2024-01-05 |
4 |
S |
$19.43 |
$339,695 |
I/I |
(17,483) |
2,276,181 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2024-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
89,520 |
272,957 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2023-08-21 |
4 |
S |
$22.59 |
$52,160 |
I/I |
(2,309) |
2,242,604 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2023-08-10 |
4 |
AS |
$25.03 |
$63,226 |
I/I |
(2,526) |
2,239,913 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2023-08-10 |
4 |
OE |
$0.68 |
$1,718 |
I/I |
2,526 |
2,242,439 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2023-04-21 |
4 |
OE |
$0.68 |
$16,864 |
I/I |
24,800 |
2,264,713 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2023-04-21 |
4 |
AS |
$25.15 |
$623,720 |
I/I |
(24,800) |
2,239,913 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2023-04-20 |
4 |
AS |
$25.00 |
$5,000 |
I/I |
(200) |
2,239,913 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2023-04-20 |
4 |
OE |
$0.68 |
$136 |
I/I |
200 |
2,240,113 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2023-02-13 |
4 |
AS |
$30.08 |
$1,017,243 |
I/I |
(33,815) |
2,239,913 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2023-02-13 |
4 |
OE |
$0.68 |
$17,000 |
I/I |
25,000 |
2,264,913 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2023-02-10 |
4 |
OE |
$0.68 |
$17,000 |
I/I |
25,000 |
2,254,031 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2023-02-10 |
4 |
AS |
$29.10 |
$727,500 |
I/I |
(25,000) |
2,229,031 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2023-02-09 |
4 |
AS |
$30.59 |
$105,015 |
I/I |
(3,433) |
2,229,031 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2023-01-05 |
4 |
S |
$28.44 |
$136,512 |
I/I |
(4,800) |
2,223,664 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2023-01-04 |
4 |
S |
$28.73 |
$144,483 |
I/I |
(5,029) |
2,213,464 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
82,240 |
231,934 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2022-08-19 |
4 |
S |
$33.22 |
$79,861 |
I/I |
(2,404) |
2,202,993 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2022-02-11 |
4 |
S |
$34.72 |
$329,528 |
I/I |
(9,491) |
2,129,648 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2022-02-10 |
4 |
OE |
$5.28 |
$399,984 |
D/D |
70,749 |
260,640 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2022-02-09 |
4 |
S |
$37.55 |
$102,104 |
I/I |
(2,719) |
2,119,442 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2022-01-05 |
4 |
S |
$44.78 |
$224,213 |
I/I |
(5,007) |
2,113,361 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
